Secret Sovaldi Hearings: Whither Transparency?
In yet another blow for transparency, the Indian patent office is apparently doing all it can to discourage members of the public from accessing the patent opposition hearings in the Sovaldi (Sofosbuvir) case. This despite the fact that this case is of monumental public importance (not just in India but internationally). And more importantly, despite the clear existence of Rule 139 of the patent rules (pointed out to be by the wonderful Feroz Ali) which states that: Hearing before the Controller […]
Secret Sovaldi Hearings: Whither Transparency? Read More »










